Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.45 |
| ▸ | GGT1 | P19440 | 1/20 | 0.43 |
| ▸ | MMP2 | P08253 | 2/20 | 0.41 |
| ▸ | MMP9 | P14780 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 5/20 | 0.40 |
| ▸ | CA1 | P00915 | 4/20 | 0.40 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.38 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.38 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.38 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.37 |
| ▸ | ACE | P12821 | 1/20 | 0.33 |
| ▸ | BMP1 | P13497 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1226472 | 1.00 | KMT2A (0.45) | KMT2AALOX15BLMPMP22GGT1 | |
| SCHEMBL6156358 | 1.00 | KMT2A (0.45) | KMT2AALOX15BLMPMP22GGT1 | |
| Trifluoroacetic Acid SCHEMBL28454353 | 0.90 | KMT2A (0.38) | KMT2AALOX15BLMPMP22GGT1 | |
| SCHEMBL1002209 | 0.89 | KMT2A (0.42) | KMT2AALOX15BLMPMP22GGT1 | |
| SCHEMBL9724019 | 0.89 | KMT2A (0.42) | KMT2AALOX15BLMPMP22GGT1 | |
| SCHEMBL149082 | 0.88 | KMT2A (0.48) | KMT2AALOX15BLMPMP22GGT1 | |
| SCHEMBL3364090 | 0.87 | NOD1 (0.42) | KMT2AALOX15BLMPMP22GGT1 | |
| SCHEMBL27546900 | 0.87 | NOD1 (0.42) | KMT2AALOX15BLMPMP22GGT1 | |
| Glutamic Acid SCHEMBL8219043 | 0.87 | ALOX15 (0.56) | KMT2AALOX15BLMPMP22FOLH1 | |
| SCHEMBL3652208 | 0.87 | NOD1 (0.44) | KMT2AALOX15BLMPMP22GGT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 727 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025262234-A1 | BIOADHESIVE MICROPARTICLE FORMULATIONS | NATIONAL UNIVERSITY OF IRELAND, GALWAY (IE) | 2025-12-26 | — | — | WO | claimed |
| WO-2025242657-A1 | LIPOPEPTIDE BUILDING BLOCKS AND AGGREGATES | SHAPE BIOPHARMACEUTICALS AG (CH) | 2025-11-27 | — | — | WO | claimed |
| CN-119722363-A | Social network community information hiding method and device guided by structural information | 杭州市滨江区浙工大人工智能创新研究院 | 2025-03-28 | — | — | CN | claimed |
| US-12188021-B2 | C5a binding nucleic acids | APTARION BIOTECH AG (DE) | 2025-01-07 | — | — | US | claimed |
| US-20240384275-A1 | C5a Binding Nucleic Acids | APTARION BIOTECH AG (DE) | 2024-11-21 | — | — | US | claimed |
| CN-118680883-A | Loadable porous structure for use as an implant | 瑞艾克斯制药公司 | 2024-09-24 | — | — | CN | claimed |
| US-12049520-B2 | Bicyclic peptide ligands specific for CD137 | BICYCLETX LIMITED (GB) | 2024-07-30 | — | — | US | claimed |
| CN-111183147-B | CD137 specific bicyclic peptide ligands | 拜斯科技术开发有限公司 | 2024-07-05 | — | — | CN | claimed |
| US-11998562-B2 | Ophthalmological formulations for the prevention of a coronavirus infection | UNIVERSITY OF SOUTH FLORIDA (US) | 2024-06-04 | — | — | US | claimed |
| CN-117247421-A | Preparation process of high-content ligustrum lucidum glycoside and osmanthus fragrans standard active substance | 上海香泉里生物科技有限公司 | 2023-12-19 | — | — | CN | claimed |
| US-6312727-B1 | SYNTHETIC POLYMER CARRIER VEHICLE FOR DELIVERY OF NUCLEIC ACID TO TARGET CELLS IN BIOLOGICAL SYSTEMS | HYBRID SYSTEMS LIMITED (GB) | 2001-11-06 | — | — | US | claimed |
| EP-1088020-A1 | FUNCTIONALISED POLYMERS OF ALPHA-AMINO ACIDS AND THE METHOD OF PREPARATION THEREOF | USTAV MAKROMOLEKULARNI CHEMIE AKADEMIE VED CESKE REPUBLIKY (CZ) | 2001-04-04 | — | — | EP | claimed |
| WO-2000074722-A2 | MODIFICATION OF BIOLOGICAL ELEMENTS | HYBRID SYSTEMS LIMITED (GB) | 2000-12-14 | — | — | WO | claimed |
| EP-0804246-B1 | DRUG DELIVERY AGENTS INCORPORATING MITOMYCIN | EUROP ECONOMIC COMMUNITY (LU) | 2000-05-17 | — | — | EP | claimed |
| WO-1999064495-A1 | FUNCTIONALISED POLYMERS OF α-AMINO ACIDS AND THE METHOD OF PREPARATION THEREOF | ÚSTAV MAKROMOLEKULÁRNÍ CHEMIE AKADEMIE VĚD ČESKÉ REPUBLIKY (CZ) | 1999-12-16 | — | — | WO | claimed |
| US-5738864-A | COVALENT COUPLING THROUGH LINKING SPACER GROUPS TO MACROMOLECULES THAT CAN SERVE AS RELATIVELY INERT POLYMERIC DRUG CARRIERS IN BIOLOGICAL SYSTEMS; SIDE EFFECT REDUCTION | EUROPEAN COMMUNITY (DE) | 1998-04-14 | — | — | US | claimed |
| EP-0804246-A1 | DRUG DELIVERY AGENTS INCORPORATING MITOMYCIN | Commission of the European Communities (LU) | 1997-11-05 | — | — | EP | claimed |
| WO-1995005200-A1 | DRUG DELIVERY AGENTS INCORPORATING MITOMYCIN | EUROPEAN COMMUNITY (LU) | 1995-02-23 | — | — | WO | claimed |
| EP-0213996-B1 | RAMIFIED POLYMERS BASED ON LIPOPEPTIDES FORMING THERMOTROPIC AND LYOTROPIC LIQUID CRYSTALS, THEIR USE AND CORRESPONDING MONOMERS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1989-09-06 | — | — | EP | claimed |
| US-4859753-A | EMULSIFIERS, FOAMING AGENTS | CENTRE NATIOONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1989-08-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12049520-B2 | Bicyclic peptide ligands specific for CD137 | CD2BP2, CD40, SDC1 | KMT2A 4692/4885ALOX15 3774/4885BLM 4274/4885 |
| US-11998562-B2 | Ophthalmological formulations for the prevention of a coronavirus infection | SARS1, ACE, ACE2 | KMT2A 4619/4885ALOX15 610/4885BLM 45/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.